Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

In the wake of the COVID-19 pandemic caused by SARS-CoV-2, questions emerged about the potential effects of Bacillus Calmette-Guérin (BCG) vaccine on the immune response to SARS-CoV-2 infection, including the neurodegenerative diseases it may contribute to. To explore this, an experimental study was...

ver descrição completa

Detalhes bibliográficos
Autores: Sánchez-Morales, Lidia, Porras, Néstor, García-Seco, Teresa, Pérez-Sancho, Marta, Cruz, Fátima, Chinchilla, Blanca, Barroso-Arévalo, Sandra, Díaz-Frutos, Marta, Buendía-Andrés, Aránzazu, Moreno, Inmaculada, Briones, Víctor, Risalde, María Ángeles, Fuente, José de la, Juste, Ramón A., Garrido, Joseba M., Balseiro, Ana, Gortázar, Christian, Rodríguez-Bertos, Antonio, Domínguez, Mercedes, Domínguez, Lucas
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Recursos:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/379566
Acesso em linha:http://hdl.handle.net/10261/379566
Access Level:acceso abierto
Palavra-chave:BCG stimulation
K18-hACE2
SARS-CoV-2
Neuroinvasion
id ES_5214278b975441cc4e27a93c7d3fdbf9
oai_identifier_str oai:digital.csic.es:10261/379566
network_acronym_str ES
network_name_str España
repository_id_str
spelling Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2Sánchez-Morales, LidiaPorras, NéstorGarcía-Seco, TeresaPérez-Sancho, MartaCruz, FátimaChinchilla, BlancaBarroso-Arévalo, SandraDíaz-Frutos, MartaBuendía-Andrés, AránzazuMoreno, InmaculadaBriones, VíctorRisalde, María ÁngelesFuente, José de laJuste, Ramón A.Garrido, Joseba M.Balseiro, AnaGortázar, ChristianRodríguez-Bertos, AntonioDomínguez, MercedesDomínguez, LucasBCG stimulationK18-hACE2SARS-CoV-2NeuroinvasionIn the wake of the COVID-19 pandemic caused by SARS-CoV-2, questions emerged about the potential effects of Bacillus Calmette-Guérin (BCG) vaccine on the immune response to SARS-CoV-2 infection, including the neurodegenerative diseases it may contribute to. To explore this, an experimental study was carried out in BCG-stimulated and non-stimulated k18-hACE2 mice challenged with SARS-CoV-2. Viral loads in tissues determined by RT-qPCR, histopathology in brain and lungs, immunohistochemical study in brain (IHC) as well as mortality rates, clinical signs and plasma inflammatory and coagulation biomarkers were assessed. Our results showed BCG-SARS-CoV-2 challenged mice presented higher viral loads in the brain and an increased frequency of neuroinvasion, with the greatest differences observed between groups at 3-4 days post-infection (dpi). Histopathological examination showed a higher severity of brain lesions in BCG-SARS-CoV-2 challenged mice, mainly consisting of neuroinflammation, increased glial cell population and neuronal degeneration, from 5 dpi onwards. This group also presented higher interstitial pneumonia and vascular thrombosis in lungs (3-4 dpi), BCG-SARS-CoV-2 mice showed higher values for TNF-α and D-dimer values, while iNOS values were higher in SARS-CoV-2 mice at 3-4 dpi. Results presented in this study indicate that BCG stimulation could have intensified the inflammatory and neurodegenerative lesions promoting virus neuroinvasion and dissemination in this experimental model. Although k18-hACE2 mice show higher hACE2 expression and neurodissemination, this study suggests that, although the benefits of BCG on enhancing heterologous protection against pathogens and tumour cells have been broadly demonstrated, potential adverse outcomes due to the non-specific effects of BCG should be considered.This research was partially funded by a REACT-European Union grant from the Comunidad de Madrid to the ANTICIPA project of Complutense University of Madrid (reference PR38/21) and partially funded by PID2020-112966RB-I00 financed by MCIN/AEI/10.13039/501100011033.Peer reviewedBioMed CentralEuropean CommissionComunidad de MadridUniversidad Complutense de MadridAgencia Estatal de Investigación (España)Ministerio de Ciencia, Innovación y Universidades (España)Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202520252024info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10261/379566reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglés#PLACEHOLDER_PARENT_METADATA_VALUE#info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2020-112966RB-I00The underlying dataset has been published as supplementary material of the article in the publisher platform at DOI 10.1186/s13567-024-01325-7https://doi.org/10.1186/s13567-024-01325-7Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/3795662026-05-22T06:33:51Z
dc.title.none.fl_str_mv Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
title Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
spellingShingle Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
Sánchez-Morales, Lidia
BCG stimulation
K18-hACE2
SARS-CoV-2
Neuroinvasion
title_short Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
title_full Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
title_fullStr Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
title_full_unstemmed Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
title_sort Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
dc.creator.none.fl_str_mv Sánchez-Morales, Lidia
Porras, Néstor
García-Seco, Teresa
Pérez-Sancho, Marta
Cruz, Fátima
Chinchilla, Blanca
Barroso-Arévalo, Sandra
Díaz-Frutos, Marta
Buendía-Andrés, Aránzazu
Moreno, Inmaculada
Briones, Víctor
Risalde, María Ángeles
Fuente, José de la
Juste, Ramón A.
Garrido, Joseba M.
Balseiro, Ana
Gortázar, Christian
Rodríguez-Bertos, Antonio
Domínguez, Mercedes
Domínguez, Lucas
author Sánchez-Morales, Lidia
author_facet Sánchez-Morales, Lidia
Porras, Néstor
García-Seco, Teresa
Pérez-Sancho, Marta
Cruz, Fátima
Chinchilla, Blanca
Barroso-Arévalo, Sandra
Díaz-Frutos, Marta
Buendía-Andrés, Aránzazu
Moreno, Inmaculada
Briones, Víctor
Risalde, María Ángeles
Fuente, José de la
Juste, Ramón A.
Garrido, Joseba M.
Balseiro, Ana
Gortázar, Christian
Rodríguez-Bertos, Antonio
Domínguez, Mercedes
Domínguez, Lucas
author_role author
author2 Porras, Néstor
García-Seco, Teresa
Pérez-Sancho, Marta
Cruz, Fátima
Chinchilla, Blanca
Barroso-Arévalo, Sandra
Díaz-Frutos, Marta
Buendía-Andrés, Aránzazu
Moreno, Inmaculada
Briones, Víctor
Risalde, María Ángeles
Fuente, José de la
Juste, Ramón A.
Garrido, Joseba M.
Balseiro, Ana
Gortázar, Christian
Rodríguez-Bertos, Antonio
Domínguez, Mercedes
Domínguez, Lucas
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv European Commission
Comunidad de Madrid
Universidad Complutense de Madrid
Agencia Estatal de Investigación (España)
Ministerio de Ciencia, Innovación y Universidades (España)
Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]
dc.subject.none.fl_str_mv BCG stimulation
K18-hACE2
SARS-CoV-2
Neuroinvasion
topic BCG stimulation
K18-hACE2
SARS-CoV-2
Neuroinvasion
description In the wake of the COVID-19 pandemic caused by SARS-CoV-2, questions emerged about the potential effects of Bacillus Calmette-Guérin (BCG) vaccine on the immune response to SARS-CoV-2 infection, including the neurodegenerative diseases it may contribute to. To explore this, an experimental study was carried out in BCG-stimulated and non-stimulated k18-hACE2 mice challenged with SARS-CoV-2. Viral loads in tissues determined by RT-qPCR, histopathology in brain and lungs, immunohistochemical study in brain (IHC) as well as mortality rates, clinical signs and plasma inflammatory and coagulation biomarkers were assessed. Our results showed BCG-SARS-CoV-2 challenged mice presented higher viral loads in the brain and an increased frequency of neuroinvasion, with the greatest differences observed between groups at 3-4 days post-infection (dpi). Histopathological examination showed a higher severity of brain lesions in BCG-SARS-CoV-2 challenged mice, mainly consisting of neuroinflammation, increased glial cell population and neuronal degeneration, from 5 dpi onwards. This group also presented higher interstitial pneumonia and vascular thrombosis in lungs (3-4 dpi), BCG-SARS-CoV-2 mice showed higher values for TNF-α and D-dimer values, while iNOS values were higher in SARS-CoV-2 mice at 3-4 dpi. Results presented in this study indicate that BCG stimulation could have intensified the inflammatory and neurodegenerative lesions promoting virus neuroinvasion and dissemination in this experimental model. Although k18-hACE2 mice show higher hACE2 expression and neurodissemination, this study suggests that, although the benefits of BCG on enhancing heterologous protection against pathogens and tumour cells have been broadly demonstrated, potential adverse outcomes due to the non-specific effects of BCG should be considered.
publishDate 2024
dc.date.none.fl_str_mv 2024
2025
2025
dc.type.none.fl_str_mv info:eu-repo/semantics/article
http://purl.org/coar/resource_type/c_6501
Publisher's version
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10261/379566
url http://hdl.handle.net/10261/379566
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv #PLACEHOLDER_PARENT_METADATA_VALUE#
info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2020-112966RB-I00
The underlying dataset has been published as supplementary material of the article in the publisher platform at DOI 10.1186/s13567-024-01325-7
https://doi.org/10.1186/s13567-024-01325-7

dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC
instname:Consejo Superior de Investigaciones Científicas (CSIC)
instname_str Consejo Superior de Investigaciones Científicas (CSIC)
reponame_str DIGITAL.CSIC. Repositorio Institucional del CSIC
collection DIGITAL.CSIC. Repositorio Institucional del CSIC
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869408007794720768
score 15,812429